9th Feb 2021 09:05
Ap19
FORM 8.3 Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 03 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
433,783 | 0.19% | 2,390,045 | 1.05% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
604,593 | 0.26% | 30,257 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 23,000 | 0.01% | 23,000 | 0.01% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,061,376 | 0.46% | 2,443,302 | 1.07% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 206.4000 USD |
Purchase | 3 | 205.6000 USD |
Purchase | 4 | 205.8700 USD |
Purchase | 4 | 209.9500 USD |
Purchase | 17 | 205.2750 USD |
Purchase | 43 | 205.7100 USD |
Purchase | 66 | 205.1600 USD |
Purchase | 66 | 204.9600 USD |
Purchase | 66 | 204.9800 USD |
Purchase | 68 | 208.1000 USD |
Purchase | 84 | 205.2800 USD |
Purchase | 100 | 205.6800 USD |
Purchase | 100 | 207.4400 USD |
Purchase | 100 | 205.2000 USD |
Purchase | 180 | 206.1932 USD |
Purchase | 181 | 208.6139 USD |
Purchase | 190 | 206.4818 USD |
Purchase | 198 | 205.2466 USD |
Purchase | 200 | 207.7900 USD |
Purchase | 305 | 209.5000 USD |
Purchase | 465 | 206.1166 USD |
Purchase | 845 | 205.7355 USD |
Purchase | 1,320 | 205.2285 USD |
Purchase | 2,142 | 205.8455 USD |
Purchase | 5,136 | 207.9604 USD |
Purchase | 5,320 | 206.6468 USD |
Purchase | 5,412 | 205.9957 USD |
Purchase | 7,284 | 206.9555 USD |
Purchase | 7,387 | 206.8826 USD |
Purchase | 9,240 | 205.8214 USD |
Purchase | 11,540 | 205.2713 USD |
Purchase | 12,595 | 206.8194 USD |
Purchase | 21,038 | 205.2700 USD |
Sale | 1 | 209.1900 USD |
Sale | 2 | 206.0500 USD |
Sale | 3 | 209.2266 USD |
Sale | 5 | 207.1600 USD |
Sale | 5 | 208.6600 USD |
Sale | 17 | 205.2750 USD |
Sale | 100 | 209.7900 USD |
Sale | 100 | 207.4600 USD |
Sale | 200 | 207.7900 USD |
Sale | 200 | 205.6000 USD |
Sale | 200 | 206.1050 USD |
Sale | 200 | 206.5875 USD |
Sale | 210 | 205.5607 USD |
Sale | 263 | 206.4946 USD |
Sale | 311 | 206.6779 USD |
Sale | 355 | 206.4525 USD |
Sale | 367 | 206.2229 USD |
Sale | 396 | 206.4971 USD |
Sale | 452 | 206.9042 USD |
Sale | 465 | 206.1166 USD |
Sale | 517 | 206.6578 USD |
Sale | 561 | 206.4974 USD |
Sale | 591 | 206.9741 USD |
Sale | 700 | 206.1884 USD |
Sale | 870 | 206.6411 USD |
Sale | 900 | 206.5833 USD |
Sale | 1,270 | 206.8187 USD |
Sale | 2,062 | 207.0021 USD |
Sale | 2,852 | 206.7412 USD |
Sale | 3,493 | 206.6225 USD |
Sale | 3,791 | 207.2624 USD |
Sale | 4,072 | 208.3637 USD |
Sale | 6,144 | 205.3333 USD |
Sale | 6,402 | 206.7873 USD |
Sale | 6,503 | 205.2728 USD |
Sale | 7,029 | 206.9696 USD |
Sale | 16,525 | 205.9275 USD |
Sale | 19,361 | 205.2700 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 9 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price |
| date |
|
| to which the option |
|
|
|
|
| or derivative |
|
|
|
|
| relates |
|
|
|
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005519/en/
Copyright Business Wire 2021
Related Shares:
Aon Cl A OrdBarclays